PARP mediates structural alterations in diabetic cardiomyopathy (Q39957001)

15 September 2017

PARP mediates structural alterations in diabetic cardiomyopathy (English)

1 reference

15 September 2017

Jane Chiu

1

1 reference

15 September 2017

Hana Farhangkhoee

2

1 reference

15 September 2017

Bing Ying Xu

3

1 reference

15 September 2017

Shali Chen

4

1 reference

15 September 2017

Biju George

5

1 reference

15 September 2017

Subrata Chakrabarti

6

1 reference

15 September 2017

8 July 2008

1 reference

Journal of Molecular and Cellular Cardiology

15 September 2017

1 reference

15 September 2017

45

1 reference

15 September 2017

3

1 reference

15 September 2017

385-393

1 reference

Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of Type 2 diabetes mellitus in OLETF rats

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

7 January 2021

Diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Eukaryotic nuclear ADP-ribosylation reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Cell surface interactions with extracellular materials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

A mouse model of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Polyol pathway-mediated changes in cardiac muscle contractile properties: studies in streptozotocin-diabetic and galactose-fed rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Oncofetal fibronectin in diabetic retinopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Histone H2A variants H2AX and H2AZ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Increased endothelin-1 and endothelin receptor expression in myocytes of ischemic and reperfused rat hearts and ventricular myocytes exposed to ischemic conditions and its inhibition by nitric oxide generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Induction of expression of the sodium-hydrogen exchanger in rat myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Heme oxygenase in diabetes-induced oxidative stress in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Transcriptional coactivation of nuclear factor-kappaB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Biochemistry and molecular cell biology of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Poly(ADP-ribose) polymerase: structure-function relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

CREB-binding protein/p300 are transcriptional coactivators of p65

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

Regulation of protein turnover by acetyltransferases and deacetylases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.009

10.1016/J.YJMCC.2008.06.009

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference